NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9853	Companies
197966	Keywords
129009	Articles
105274	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 09/17/2025 at 22:15, 4 months 24 days ago

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed

Melanoma NANOBIOTIX Immune Checkpoint Inhibitors Phase 1 Study JNJ-1900
PRESS RELEASE

published on 09/17/2025 at 22:15, 4 months 24 days ago

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-P
NanoBiotix annonce de nouveaux résultats de phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

NANOBIOTIX Phase 1 Inhibiteurs De Points De Contrôle JNJ-1900 Mélanome Cutané
BRIEF

published on 09/12/2025 at 19:05, 4 months 29 days ago

Nanobiotix Announces Voting Rights and Share Capital Details

Voting Rights Shares Euronext Nasdaq NANOBIOTIX
BRIEF

published on 09/12/2025 at 19:05, 4 months 29 days ago

Nanobiotix annonce les droits de vote et le détail du capital social

Euronext Actions Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE

published on 09/12/2025 at 19:00, 4 months 29 days ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Communiqué de presse sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations financières clés et activités de l'entreprise

Droits De Vote Capital Social Biotechnologie Actions NANOBIOTIX
PRESS RELEASE

published on 09/12/2025 at 19:00, 4 months 29 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix releases voting rights and shares capital details. The company is listed on Euronext Paris and Nasdaq, pioneering biotechnology for treatment advancements

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 09/02/2025 at 22:20, 5 months 9 days ago

Nanobiotix à la conférence H.C. Wainwright Global Investment

Biotechnologie Investisseurs Conference NANOBIOTIX Thérapeutiques
BRIEF

published on 09/02/2025 at 22:20, 5 months 9 days ago

Nanobiotix at the HC Wainwright Global Investment Conference

Investors Biotechnology Conference Therapeutics NANOBIOTIX
PRESS RELEASE

published on 09/02/2025 at 22:15, 5 months 9 days ago

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
Nanobiotix participe à la conférence investisseurs annuelle H.C. Wainwright Global Investment pour présenter ses avancées en biotechnologie pour le traitement du cancer et d'autres maladies

Biotechnologie Conférence Investisseurs Cancer NANOBIOTIX Maladies
PRESS RELEASE

published on 09/02/2025 at 22:15, 5 months 9 days ago

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases

Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments

Accesswire

Published on 02/12/2026 at 15:00, 1 hour 19 minutes ago

Onco-Innovations Announces Amendment to Private Placement Pricing
Published on 02/12/2026 at 14:30, 1 hour 49 minutes ago

MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/12/2026 at 14:30, 1 hour 49 minutes ago

Loar Holdings Inc. Announces Date and Time for Fourth Quarter and Full Year 2025 Earnings Conference Call
Published on 02/12/2026 at 14:22, 1 hour 57 minutes ago

Worksport Confirms Government Evaluation of Aetherlux(TM) Heat Pump for Potential Long-Term Supply Deal; Certification Accelerated
Published on 02/12/2026 at 14:00, 2 hours 19 minutes ago

Diamond Drilling Confirms Wide Gold Intercept in Northeast Extension of North Pipe at Colosseum

View all ACCESSWIRE

EQS Group

Published on 02/12/2026 at 16:06, 13 minutes ago

EQS-Adhoc: Siltronic AG: Siltronic releases its guidance for financial year 2026
Published on 02/12/2026 at 15:51, 28 minutes ago

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
Published on 02/12/2026 at 15:51, 28 minutes ago

Senken and Exomad Green Sign Offtake Agreement for 105,000 Tonnes of Carbon Removal for Aviation
Published on 02/12/2026 at 15:51, 28 minutes ago

CGTN：How China is strengthening rural specialty industries to promote rural revitalization
Published on 02/12/2026 at 15:50, 29 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 02/12/2026 at 07:30, 8 hours 49 minutes ago

Press release - Carrefour announces the sale of Carrefour Romania
Published on 02/12/2026 at 07:30, 8 hours 49 minutes ago

Communiqué de presse - Carrefour annonce la cession de Carrefour Roumanie
Published on 02/12/2026 at 07:00, 9 hours 19 minutes ago

TERACT - H1 2025-2026 Revenue
Published on 02/12/2026 at 07:00, 9 hours 19 minutes ago

TERACT - Chiffre d’affaires du 1er semestre 2025-2026
Published on 02/11/2026 at 17:45, 22 hours 34 minutes ago

Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.

View all LES ECHOS COMFI WIRE